France Archives

News and Trends 7 Jul 2016

Engineered Microorganisms now able to directly produce Bioplastics for 3D-Printing

Carbios made a breakthrough in the production of PLA, a common bioplastic. The lactic acid used as molecular ‘building blocks’ were already bio-sourced, but now the plastic can be really produced from scratch with microorganisms. Bioplastics are one of the ways GreenTech is trying to save the world. Some success stories are Bio-On’s potato plastics […]

July 7, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 6 Jul 2016

June was a Tough Month for European Biotech… #Fail

Abivax, Celyad, Circassia and Genticel – these are all European Biotechs that took a hit after failing key clinical trials in June. How are they doing now? Four different public Biotechs suffered setbacks in some of their advanced clinical trials. And, as always, the words ‘failed to meet primary endpoint‘ weren’t very popular with investors… […]

July 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 29 Jun 2016

How to Survive the Valley of Death as a Biotech Startup?

Over the past decade there has been an unprecedented restructuring of R&D in pharma whereas building a successful biotech company is still as challenging. How can these two elements help each other? This is a contributing post from Peter Machin, former SVP Drug Discovery at GSK. Big Pharma has significantly contracted its in-house […]

June 29, 2016 - 5 minutesmins - By External Contributor

News and Trends 27 Jun 2016

Genticel is facing hard Times Again!

As presented last week, Genticel was getting back on track with the announcement of two major milestones with the aim to prepare the phase III. However, the major outcomes of its Phase II were expected to be presented on the 17th of June at Eurogin 2016 Congress… Here they are (and they are really bad)! GTL001 is […]

June 27, 2016 - 2 minutesmins - By Jerome Topsent

News and Trends 27 Jun 2016

“France has always been a Leader in Infectious Disease and Microbiology”

This is what Franck Lescure, a partner at VC firm Auriga Partners, told me when I met him in Paris at his office next to the Champs-Elysées. Their last fund, Auriga IV Bioseeds, focuses on infectious disease and microbiology, with 6 investments so far and 9 by the end of 2016. It was a great way to […]

June 27, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 23 Jun 2016

Cellectis gets paid for a first Milestone, Investors are pleased

After successfully ‘saving’ two babies with terminal-stage acute Leukemia, Cellectis finally treated the first patient in its Phase I trial. A major milestone that could confirm the potential of its lead candidate UCART-19. It’s once again a success for the French biotech company! As it announced on Monday, the first patient has been treated in […]

June 23, 2016 - 2 minutesmins - By Jerome Topsent

News and Trends 22 Jun 2016

What is Microsoft doing with this French Precision Medicine Biotech?

Median Technologies is partnering up with software giant Microsoft to integrate big data into its oncology imaging systems – and deliver Precision Medicine from the cloud. Medical imaging is an important part of the rise of digital medicine. Cool projects in the field include the aortic graft simulation of EVARplanning (one of the startups at Italian incubator […]

June 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

labiotech refresh microbiome isabelle cremoux

News and Trends 21 Jun 2016

“The Microbiome will be as big as Biotech in 10 Years”

Isabelle de Cremoux, the CEO of Seventure Partners, was at Labiotech Refresh to tell us when and how she fell in love with the microbiome and what the future holds for this exciting field. De Cremoux is the person behind Seventure, one of the top European VCs and the first in the world to focus mainly […]

June 21, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 17 Jun 2016

After its drop earlier this year, Genticel goes back up the slope

Genticel has announced that not one but two milestones have been achieved in the development of its products, which focus on immunotherapies for cancers caused by the human papillomavirus. Genticel is developing GTL001 (named ProCervix in Europe) to answer an unmet medical need – the eradication of the virus HPV 16 or 18 (high-risk types that […]

June 17, 2016 - 3 minutesmins - By Jerome Topsent

allecra forbion delos antibiotic resistance

News and Trends 16 Jun 2016

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Allecra Therapeutics has raised €22M in its Series B round from some key investors. The money will back the Phase II trials for a new broad-spectrum antibiotic for resistant bacteria. The development of antibiotic resistance in bacteria has been one of the key concerns of healthcare authorities for quite some time. The World Health Organisation estimates […]

June 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

crispr therapeutics muscle stem cells anagenesis

News and Trends 10 Jun 2016

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

CRISPR Therapeutics has struck a deal with Anagenesis Biotechnologies, which has key technology for muscle stem cells. Together, they will tackle muscle disorders – including the rare disease Duchenne Muscular Dystrophy (DMD). CRISPR Therapeutics (Basel, Switzerland) is the European champion of gene editing for health applications, a field that promises to revolutionize therapies – even if […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Jun 2016

Genticel is vaccinating against Cervical Cancer AFTER Infection

Estonia, our previous destination by the Baltic Sea, was a delightful and a full of potential place to visit. This week, we are heading down to the relaxing and sunny south of France, more precisely to Toulouse, once the capital of the Visigothic Kingdom and current to the Midi-Pyrénées region, the largest region in metropolitan France. It […]

June 10, 2016 - 2 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

Engineered Microorganisms now able to directly produce Bioplastics for 3D-Printing

June was a Tough Month for European Biotech… #Fail

How to Survive the Valley of Death as a Biotech Startup?

Genticel is facing hard Times Again!

“France has always been a Leader in Infectious Disease and Microbiology”

Cellectis gets paid for a first Milestone, Investors are pleased

What is Microsoft doing with this French Precision Medicine Biotech?

“The Microbiome will be as big as Biotech in 10 Years”

After its drop earlier this year, Genticel goes back up the slope

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Genticel is vaccinating against Cervical Cancer AFTER Infection

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!